The discontinuation rate range is wider, suggesting that tolerability varies more between individuals with the triple agonist
GLP Trackr is available on the App Store and Google Play snap your meals, log your progress, and start a free 7-day trial to see your journey in one place
Not every patient will be approved for every IV or every nutrient.
It calls for coordinated research, regulatory action, professional engagement and equitable, timely adoption of effective therapies
However, its vital to approach their usage cautiously, under medical supervision, due to potential side effects and regulatory concerns
The most commonly reported adverse reactions are gastrointestinal in nature, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort